Pirfenidone, an Antifibrotic and Antiinflammatory Drug
Condition(s):Fibrosis; Hepatitis C ChronicLast Updated:July 9, 2014Completed
Hide Studies Not Open or Pending
Condition(s):Fibrosis; Hepatitis C ChronicLast Updated:July 9, 2014Completed
Condition(s):ObesityLast Updated:January 5, 2018Completed
Condition(s):Partial Edentulism; Tooth DiseaseLast Updated:March 29, 2022Completed
Condition(s):PK for FG-4592; Healthy SubjectsLast Updated:June 12, 2014Completed
Condition(s):Uncontrolled AsthmaLast Updated:August 28, 2018Completed
Condition(s):Healthy VolunteersLast Updated:October 3, 2018Completed
Condition(s):Schizophrenia; Alcohol Use DisorderLast Updated:October 8, 2021Completed
Condition(s):Postoperative Pain; Postoperative Nausea and Vomiting; Quality of LifeLast Updated:April 16, 2020Terminated
Condition(s):Testicular Neoplasms; Germ Cell TumorsLast Updated:June 12, 2014Completed
Condition(s):Triple-negative Breast CancerLast Updated:August 19, 2021Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.